Symbol="XERS"
AssetType="Common Stock"
Name="Xeris Pharmaceuticals Inc"
Description="Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois."
CIK="1867096"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="180 N. LASALLE STREET, SUITE 1600, CHICAGO, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="324054000"
EBITDA="-45258000"
PERatio="None"
PEGRatio="None"
BookValue="0.219"
DividendPerShare="0"
DividendYield="0"
EPS="-0.51"
RevenuePerShareTTM="0.891"
ProfitMargin="-0.641"
OperatingMarginTTM="-0.474"
ReturnOnAssetsTTM="-0.109"
ReturnOnEquityTTM="-1.23"
RevenueTTM="121371000"
GrossProfitTTM="87614000"
DilutedEPSTTM="-0.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.504"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.849"
PriceToBookRatio="3.409"
EVToRevenue="2.362"
EVToEBITDA="-2.101"
Beta="1.81"
num_52WeekHigh="3.07"
num_52WeekLow="0.97"
num_50DayMovingAverage="2.678"
num_200DayMovingAverage="1.742"
SharesOutstanding="137311000"
DividendDate="None"
ExDividendDate="None"
symbol="XERS"
open="2.42"
high="2.50"
low="2.32"
price="2.36"
volume="1274864.00"
latest_trading_day="2023-07-07"
previous_close="2.41"
change="-0.05"
change_percent="-2.0747%"
aroon_positive_momentum_days="85"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="1285022"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="0.53"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="500"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_negative_thumbnail_id_2="99"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="1011"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
